Who Has Mounjaro in Stock Right Now — and How to Get It Safely

The biggest myth: you can check who has Mounjaro 'in stock' the same way you'd check for paracetamol

Mounjaro isn't sitting on a chemist's shelf waiting for whoever arrives first. It's a Prescription-Only Medicine, which means UK law requires a prescriber to assess you before any pharmacy can lawfully supply it. No assessment, no prescription, no medicine. That's not a bureaucratic inconvenience, it's the mechanism that keeps counterfeit pens out of your hands and genuine treatment matched to people for whom it's clinically right.

The MHRA has issued repeated warnings about fake weight-loss pens sold through social media and unofficial websites, people offering tirzepatide without a prescription, often at suspiciously low prices. In October 2025 the MHRA raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens, seizing roughly 20 million doses worth around £45 million. If you're wondering where Mounjaro is actually in stock and a result looks like an informal seller, that's the pattern to avoid. You can report suspect sellers at the MHRA Yellow Card portal.

The right question isn't 'who has it on the shelf', it's 'which regulated, verifiable service can prescribe and supply it for me today'. If you want a practical answer to who has Mounjaro in stock near you, understanding how regulated supply actually works is the right place to start.

How to get Mounjaro in the UK: the actual steps

The process through a regulated online pharmacy is straightforward. You complete a clinical consultation, medical history, current medicines, weight, any relevant conditions. At nume, a GPhC-registered Independent Prescriber then reads those answers personally. If you're approved as clinically suitable, a prescription is issued, the order is packed by our own GPhC-registered pharmacy (premises number 9012878, verifiable on the GPhC register), and dispatched same day if your consultation clears before noon. DPD delivers the next working day, tracked, discreet, no clue what's inside from the outside.

If you've been on treatment elsewhere and want to transfer, that's covered in the consultation too. Checking current Mounjaro availability through a legitimate route is part of what our prescribers manage, including which strengths are moving through the licensed UK supply chain.

For anyone asking specifically about a particular dose, our 5mg stock information page covers what affects availability at that tier and what a prescriber considers when titration timing matters. Dose availability is confirmed during your clinical review, not before it, that's how a safe service works.

You can also verify any online pharmacy you're considering by searching the GPhC pharmacy register before you hand over personal or payment details. If you'd like to buy Mounjaro stock through a regulated provider, confirming a GPhC registration number and a named superintendent pharmacist are the minimum steps before proceeding. If a site doesn't show both, stop.

Who the licensed eligibility criteria actually cover

Mounjaro is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol, obstructive sleep apnoea, prediabetes or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Those are the licence parameters, not a guarantee of approval, a prescriber looks at the full picture, including any medicines you're taking and your medical history.

If you're wondering whether you'd qualify and don't want to wait for an NHS referral, our weight loss treatment overview sets out how the private route works alongside the NHS pathway. The clinical team profile at our lead prescriber's page is there if you want to understand who would be reviewing your case. For those researching specific providers, the Evans Pharmacy Mounjaro page is a useful example of what transparent, regulated supply looks like in practice. NICE's guidance on tirzepatide (TA1026, published December 2024) also sets out the evidence base the recommendation draws on, which is useful reading if you want the full clinical context before starting.

One thing worth knowing before you start comparing providers: for a prescription medicine, the cheapest listing answers the wrong question. Supply chain, clinical oversight and genuine GPhC registration are the measures that matter. Worth checking.